Search Result

Results for "

lactic

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (1) Amino Acid Derivatives (1) AMPK (1) Antibiotic (3) Apoptosis (5) Aurora Kinase (1) Autophagy (1) Bacterial (5) Bcr-Abl (1) Biochemical Assay Reagents (5) Endogenous Metabolite (9) FLT3 (1) Fluorescent Dye (1) Glucosidase (1) Isotope-Labeled Compounds (9) JAK (1) Mitochondrial Metabolism (1) Neuropeptide Y Receptor (1) NKCC (1) PDHK (1) Reactive Oxygen Species (2)
By Research Areas:	Cancer (10) Infection (3) Inflammation/Immunology (3) Metabolic Disease (10) Neurological Disease (3)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B2227B

Lactate sodium 3 Publications Verification lactic acid sodium	Others	Metabolic Disease
Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis . Lactate (Lactic acid) sodium is an organic salt that is mainly used as a buffer and pH adjuster for injection solutions. Lactate sodium can be metabolized by the body into sodium bicarbonate, which in turn acts to increase the pH of the blood. Lactate sodium is used to improve metabolic acidosis and hypovolemic states. In terms of pharmaceutical preparations, Lactate sodium is often used in combination with sodium chloride, glucose, etc. to form normal saline or compound liquid intravenous injection . Lactate sodium also has antimicrobial activity, which can be used as a food preservative .

HY-B2227BS2

Lactate-13C sodium lactic acid-¹³C sodium	Isotope-Labeled Compounds	Metabolic Disease
Lactate- ¹³C (sodium) is the ¹³C labeled Lactate sodium[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2].

HY-B2227A

Lactate calcium 3 Publications Verification lactic acid calcium	Bacterial	Cancer
Lactate (Lactic acid) calcium is used by the beverage industry as a source of calcium to fortify fruit juice. Lactate calcium facilitates the growth and phytic acid degradation of soybean sprouts .

HY-B2227

Lactate 3 Publications Verification lactic acid	Endogenous Metabolite	Metabolic Disease Inflammation/Immunology Cancer
Lactate (Lactic acid) is a hydroxycarboxylic acid receptor 1 (HCAR1) activator and an epigenetic modulator inducing lysine residues lactylation. Lactate is a glycolysis end-product, bridging the gap between glycolysis and oxidative phosphorylation. Lactate is an oncometabolite and has immune protective role of lactate in anti-tumor immunity .

HY-B2227C

Lactate potassium lactic acid potassium	Bacterial	Infection Others
Lactate (Lactic acid) potassium is used as a sodium chloride substitute in the elaboration of dry meat products. Lactate potassium (56%) and sodium diacetate (4%) mixture inhibit the development of L. sake and L. monocytogenes bacteria at 4℃ to extend the shelf life of food .

HY-B2227BS3

Lactate-13C-1 sodium lactic acid-¹³C-1 sodium	Isotope-Labeled Compounds	Metabolic Disease
Lactate- ¹³C-1 (sodium) is the ¹³C labeled Lactate (sodium)[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2].

HY-B2227BS

Lactate-d4 sodium lactic acid-d₄ sodium	Isotope-Labeled Compounds	Others
Lactate-d₄ (sodium) is the deuterium labeled Lactate sodium. Lactate sodium is the product of glycogenolysis and glycolysis. Lactate sodium functions in a variety of biochemical processes[1][2].

HY-B2227BS1

Lactate-d3 sodium lactic acid-d₃ sodium	Isotope-Labeled Compounds	Others
Lactate-d₃ (sodium) is the deuterium labeled Lactate sodium. Lactate sodium is the product of glycogenolysis and glycolysis. Lactate sodium functions in a variety of biochemical processes[1][2].

HY-Y0479

*L-Lactic* acid** 4 Publications Verification (S)-2-Hydroxypropanoic acid
L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.

HY-Y0479S3

*L-Lactic* acid-2-13C1**	Bacterial Endogenous Metabolite Antibiotic	Infection
L-Lactic acid-2- ¹³C₁ is the ¹³C-labeled L-Lactic acid. L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.

HY-113099

Indolelactic acid 2 Publications Verification Indole-3-lactic acid	Endogenous Metabolite	Inflammation/Immunology
Indolelactic acid (Indole-3-lactic acid) is a tryptophan (Trp) catabolite in Azotobacter vinelandii cultures. Indolelactic acid has anti-inflammation and potential anti-viral activity .

HY-141540

Lactyl-CoA	Others	Others
Lactyl-CoA is an acyl-CoA formally condensed from the sulfhydryl group of CoA and the carboxyl group of lactic acid, also known as lactyl-CoA. Lactyl-CoA is essential for the biosynthesis of biodegradable and biocompatible lactic acid-based copolymers .

HY-111095S2

*D-(-)-Lactic* acid-13C-1** (R)-2-Hydroxypropionic acid-¹³C-1; D-lactic acid-¹³C-1	Endogenous Metabolite	Others
D-(-)-Lactic acid- ¹³C-1 is the ¹³C labeled D-(-)-Lactic acid. D-(-)-Lactic acid is a normal intermediate in the fermentation (oxidation, metabolism) of sugar. D-(-)-Lactic acid is identified to be a competitive inhibitor of ProDH (proline dehydrogenase) in plants .

HY-10058

*AT9283 lactic* acid**	JAK Aurora Kinase Bcr-Abl FLT3 Apoptosis Autophagy	Cancer
AT9283 lactic acid is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC₅₀s ranging from 1 to 30 nM). AT9283 lactic acid inhibits growth and survival of multiple solid tumors in vitro and in vivo .

HY-111095B

*D-(-)-Lactic* acid sodium** (R)-2-Hydroxypropionic acid sodium	Endogenous Metabolite	Metabolic Disease
D-(-)-Lactic acid ((R)-2-Hydroxypropionic acid ) sodium is an endogenous metabolite.

HY-141941S

Triazole Lactic Acid-13C2, 15N3

Isotope-Labeled Compounds Others

Triazole Lactic Acid- ¹³C₂, ¹⁵N₃ is the ¹³C and ¹⁵N labeled Triazole Lactic Acid[1].

*Triazole Lactic* Acid-13C2, 15N3**	Isotope-Labeled Compounds	Others
Triazole Lactic Acid- ¹³C₂, ¹⁵N₃ is the ¹³C and ¹⁵N labeled Triazole Lactic Acid[1].

HY-111095S1

*D-(-)-Lactic* acid-13C** (R)-2-Hydroxypropionic acid-¹³C; D-lactic acid-¹³C	Isotope-Labeled Compounds	Others
D-(-)-Lactic acid-13C ((R)-2-Hydroxypropionic acid-13C) is a ¹³C-labeled D-Lactic acid. D-(-)-Lactic acid-13C can be used as an internal standard and can also be used in studies such as metabolic tracing.

HY-Y0479S

*L-Lactic* acid-13C3** (S)-2-hydroxypropanoic-13-C3	Antibiotic Endogenous Metabolite Bacterial Isotope-Labeled Compounds	Metabolic Disease
L-Lactic acid- ¹³C₃ is a stable isotope labeled L-Lactic acid analog. L-Lactic acid- ¹³C₃ can be used for lactate metabolism research[1].

HY-111095S3A

*D-(-)-Lactic* acid-13C-2 sodium** (R)-2-Hydroxypropionic acid-¹³C-2 sodium; D-lactic acid-¹³C-2 sodium	Isotope-Labeled Compounds	Others
D-(-)-Lactic acid-13C-2 (sodium) is a sodium. D-(-)-Lactic acid-13C-2 (sodium) can be used for a variety of biochemical studies.

HY-D0884

*L-Lactic* acid lithium** (S)-2-Hydroxypropanoic acid lithium
L-Lactic acid (lithium) is a chemical compound belonging to the class of lithium salts. It is commonly used in the pharmaceutical industry as a mood stabilizer and antipsychotic for the improvement of bipolar disorder and schizophrenia. L-Lactic acid (lithium) works by affecting the balance of certain chemicals in the brain, which can help reduce symptoms such as mood swings, aggression, and hallucinations.

HY-Y0479AS

*L-Lactic* acid-13C3 sodium** (S)-2-hydroxypropanoic-¹³C₃ sodium	Antibiotic Endogenous Metabolite Bacterial Isotope-Labeled Compounds	Metabolic Disease
L-Lactic acid- ¹³C₃ (sodium) is the ¹³C labeled L-Lactic acid. L-Lactic acid- ¹³C₃ sodium can be used for lactate metabolism research[1].

HY-B2247

PLGA (50:50) 5+ Cited Publications poly(lactic-co-glycolic acid) (50:50)	Biochemical Assay Reagents	Others
PLGA (50:50) (poly(lactic-co-glycolic acid) (50:50)) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications.

HY-N9274

*3-Hydroxy-3-(4-hydroxyphenyl)-lactic* acid**	Others	Others
3-Hydroxy-3-(4-hydroxyphenyl)-lactic acid is a key metabolite in the P. roqueforti fermentation approach, with quantitative data of 10.2 ± 1.1 µM in Tyr ¹ (presence of L-tyrosine) of .

HY-107727

*BMS-193885 L-Lactic* acid**	Neuropeptide Y Receptor	Neurological Disease
BMS-193885 (L-Lactic acid) is a potent, selective, and brain-penetrant neuropeptide Y1 receptor antagonist. BMS-193885 has a K_i value of 3.3 nM for the neuropeptide Y1 receptor, competitively acts on the neuropeptide Y binding site, and can reduce food intake and body weight through central Y1 inhibition .

HY-B2247A

PLGA (75:25) poly(lactic-co-glycolic acid) (75:25)	Biochemical Assay Reagents	Others
PLGA (75:25) is a low toxicity, biocompatible and biodegradable controlled drug delivery carrier, can achieve slow release in the organism. PLGA (75:25) is a copolymer of 75% poly lactic acid (PLA) and 25% poly glycolic acid (PGA). PLGA (75:25) has been extensively studied as delivery vehicles for agents, proteins and various other macromolecules such as DNA, RNA and peptides .

HY-Y0445A

Sodium dichloroacetate Maximum Cited Publications 14 Publications Verification	PDHK Reactive Oxygen Species NKCC Apoptosis	Cancer
Sodium dichloroacetate is a metabolic regulator in cancer cells' mitochondria with anticancer activity. Sodium dichloroacetate inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. Sodium dichloroacetate increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. Sodium dichloroacetate also works as NKCC inhibitor .

HY-N8139

2-Amino-3-carboxy-1,4-naphthoquinone	Others	Metabolic Disease
2-Amino-3-carboxy-1,4-naphthoquinone is the electron transfer mediator. 2-Amino-3-carboxy-1,4-naphthoquinone changes glucose metabolism of the homofermentative lactic acid bacteria .

HY-113133

Kojibiose	Glucosidase	Infection Metabolic Disease Inflammation/Immunology
Kojibiose, an orally active prebiotic disaccharide, can specifically inhibit the activity of α-glucosidase I. kojibiose is a proliferation factor for Bifidobacterium, lactic acid bacteria, and eubacteria. kojibiose is a low-calorie sweetener capable of increasing the absorption of iron. Kojibiose exhibits antitoxic activity. Kojibiose reduces hepatic expression of inflammatory markers in vivo .

HY-B1530

Ammonium lactate (±)-Ammonium lactate
Ammonium lactate is the ammonium salt of lactic acid, with mild anti-bacterial properties. Ammonium lactate can be used for the research of xerosis .

HY-W040233

Sodium (S)-2-hydroxypropanoate 4 Publications Verification Sodium L-lactate	Others	Others
Sodium (S)-2-hydroxypropanoate (Sodium L-lactate) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid .

HY-W040233B

Sodium (S)-2-hydroxypropanoate (purity≥90%) Sodium L-lactate (purity≥90%)	Others	Others
Sodium (S)-2-hydroxypropanoate (Sodium L-lactate) (purity≥90%) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid .

HY-136593

(S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid (S)-3-(4-Hydroxyphenyl)lactic acid	Others	Others
(S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid (compound 1) is a metabolite isolated from the culture medium of Leuconostoc mesenteroides. (S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid has high DPPH radical-scavenging activities and antioxidative activities .

HY-130117

AlbA-DCA	Reactive Oxygen Species Apoptosis	Cancer
AlbA-DCA is a conjugate formed by the attachment of Albiziabioside A (AlbA) to a dichloroacetate acid (DCA) subunit. AlbA-DCA can induce a marked increase in intracellular ROS and alleviate the accumulation of lactic acid in tumor microenvironment (TME), and also selectively kills cancer cells and induce apoptosis .

HY-113099S

Indolelactic acid-d5 Indole-3-lactic acid-d₅	Endogenous Metabolite	Others
Indolelactic acid-d₅ is the deuterium labeled Indolelactic acid. Indolelactic acid is a tryptophan (Trp) catabolite in Azotobacter vinelandii cultures.

HY-W005288

4-Vinylphenol	Apoptosis Endogenous Metabolite	Cancer
4-Vinylphenol is found in the medicinal herb Hedyotis diffusa Willd, wild rice and is also the metabolite of p-coumaric and ferulic acid by lactic acid bacteria in wine. 4-Vinylphenol induces apoptosis and inhibits blood vessels formation and suppresses invasive breast tumor growth in vivo .

HY-W002299

Boc-D-Leucine monohydrate Boc-D-Leu-OH hydrate	Amino Acid Derivatives	Neurological Disease
Boc-D-Leucine monohydrate (Boc-D-Leu-OH hydrate) is an N-Boc-protected form of D-Leucine (L330150). D-Leucine is an unnatural isomer of L-Leucine (L330110) that acts as an auto-inhibitor of lactic streptococci. D-Leucine shows potent anti-seizure effect .

HY-16397

Phenformin Phenethylbiguanide	Mitochondrial Metabolism AMPK Apoptosis	Metabolic Disease Cancer
Phenformin (1-phenethylbiguanide) is an orally active antidiabetic and anticancer agent. Phenformin has an incidence of associated lactic acidosis. Phenformin acts through acting AMPK activation and blocking mTOR pathway. Phenformin is also a substrate of P-glycoprotein (P-gp), and an OXPHOS inhibitor. Phenformin induces cancer cell apoptosis .

HY-Y0335

1,3-Dihydroxyacetone Dihydroxyacetone
1,3-Dihydroxyacetone (DHA), the main active ingredient in sunless tanning skin-care preparations and an important precursor for the synthesis of various fine chemicals, is produced on an industrial scale by microbial fermentation of glycerol (HY-B1659) in Gluconobacter oxydans. 1,3-Dihydroxyacetone is also used for synthesis of new biodegradable polymers by combining with lactic acid (HY-B2227) .

HY-D0153

Tetramethylrhodamine-5-isothiocyanate	Fluorescent Dye	Cancer
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .

HY-129101

(-)-Eseroline fumarate Eseroline fumarate	5-HT Receptor	Neurological Disease
(-)-Eseroline fumarate is a metabolic of Physostigmine (HY-N6608), an AChE inhibitor. (-)-Eseroline fumarate elicits a leakage of lactic acid dehydrogenase (LDH) from cancer cells. (-)-Eseroline fumarate also induces the release of adenine nucleotides and 5-hydroxytryptamine (5-HT) from neuronal cells, thus induce cell death. (-)-Eseroline fumarate inhibits the electrically evoked twitches of the mouse vas deferens and of the guinea-pig ileum .

HY-156829

PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1)	Others	Cancer
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 1:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 1:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity .

HY-156829A

PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1)	Others	Cancer
PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) is a matrix materia, with lactic acid (LA)：glycolic acid (GA) = 15:1, that acts as anti-cancer drug delivery. PLGA-PEG-PLGA (1500-1500-1500) (LA/GA 15:1) can improve a drug's bioavailability, efficacy, water solubility, drug encapsulation efficiency, sustained drug release, and to minimize undesirable toxicity .

HY-148775

PLGA-PEG-MAL (60kDA-3.4kDA, LA:GA ratio 75:25)	Biochemical Assay Reagents	Others
PLGA-PEG-MAL (60kDA-3.4kDA, LA:GA ratio 75:25) is a kind of poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG-Mal) nanoparticles. PLGA-PEG-MAL (60kDA-3.4kDA, LA:GA ratio 75:25) has a molecular weight of 60kDA to 3.4kDA and contains a 75:25 ratio of lactic acid (LA) to glycolic acid (GA) molecules .

HY-148775B

PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 40:60)	Biochemical Assay Reagents	Others
PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 40:60) is a kind of poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG-Mal) nanoparticles. PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 40:60) has a molecular weight of 60kDA to 3.4kDA and contains a 75:25 ratio of lactic acid (LA) to glycolic acid (GA) molecules .

HY-148776

PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 50:50)	Biochemical Assay Reagents	Others
PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 50:50) is a kind of poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG-Mal) nanoparticles. PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 50:50) has a molecular weight of 20kDA to 5.0kDA and contains a 50:50 ratio of lactic acid (LA) to glycolic acid (GA) molecules. The molecular ratio of LA to GA determines the rate of matrix degradation and protein re-release .

Cat. No.	Product Name	Type

HY-D0153

Tetramethylrhodamine-5-isothiocyanate	Fluorescent Dyes/Probes
Tetramethylrhodamine-5-isothiocyanate is a potent fluorescent dye. Tetramethylrhodamine-5-isothiocyanate can be used for label PG-M3 antibody for rapid diagnosis of acute promyelocytic leukemia (APL). Tetramethylrhodamine-5-isothiocyanate can be used as probe to quantify in vivo the biodistribution of PLGA (poly(lactic-co-glycolic) acid) and PLGA/chitosan nanoparticles .

Cat. No.	Product Name	Type

HY-B2247

PLGA (50:50) 5+ Cited Publications poly(lactic-co-glycolic acid) (50:50)	Drug Delivery
PLGA (50:50) (poly(lactic-co-glycolic acid) (50:50)) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications.

Cat. No.	Product Name	Target	Research Area

HY-W002299

Boc-D-Leucine monohydrate Boc-D-Leu-OH hydrate	Amino Acid Derivatives	Neurological Disease
Boc-D-Leucine monohydrate (Boc-D-Leu-OH hydrate) is an N-Boc-protected form of D-Leucine (L330150). D-Leucine is an unnatural isomer of L-Leucine (L330110) that acts as an auto-inhibitor of lactic streptococci. D-Leucine shows potent anti-seizure effect .

HY-P4519

Ac-Lys(Ac)-D-Ala-D-Lactic acid

Peptides Others

Ac-Lys(Ac)-D-Ala-D-Lactic acid is a depsipeptide substrate for penicillin-sensitive D-alanine carboxypeptidases (DD-carboxypeptidases) .

HY-P4837

*Ac-Lys-D-Ala-D-lactic* acid**	Peptides	Others
Ac-Lys-D-Ala-D-lactic acid is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .

Cat. No.	Product Name	Chemical Structure

HY-B2227BS2

Lactate-13C sodium
Lactate- ¹³C (sodium) is the ¹³C labeled Lactate sodium[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2].

HY-B2227BS

Lactate-d4 sodium
Lactate-d₄ (sodium) is the deuterium labeled Lactate sodium. Lactate sodium is the product of glycogenolysis and glycolysis. Lactate sodium functions in a variety of biochemical processes[1][2].

HY-B2227BS1

Lactate-d3 sodium
Lactate-d₃ (sodium) is the deuterium labeled Lactate sodium. Lactate sodium is the product of glycogenolysis and glycolysis. Lactate sodium functions in a variety of biochemical processes[1][2].

HY-B2227BS3

Lactate-13C-1 sodium
Lactate- ¹³C-1 (sodium) is the ¹³C labeled Lactate (sodium)[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2].

HY-Y0479S3

*L-Lactic* acid-2-13C1**
L-Lactic acid-2- ¹³C₁ is the ¹³C-labeled L-Lactic acid. L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.

HY-111095S2

*D-(-)-Lactic* acid-13C-1**
D-(-)-Lactic acid- ¹³C-1 is the ¹³C labeled D-(-)-Lactic acid. D-(-)-Lactic acid is a normal intermediate in the fermentation (oxidation, metabolism) of sugar. D-(-)-Lactic acid is identified to be a competitive inhibitor of ProDH (proline dehydrogenase) in plants .

HY-141941S

Triazole Lactic Acid-13C2, 15N3

Triazole Lactic Acid- ¹³C₂, ¹⁵N₃ is the ¹³C and ¹⁵N labeled Triazole Lactic Acid[1].

HY-111095S1

*D-(-)-Lactic* acid-13C**
D-(-)-Lactic acid-13C ((R)-2-Hydroxypropionic acid-13C) is a ¹³C-labeled D-Lactic acid. D-(-)-Lactic acid-13C can be used as an internal standard and can also be used in studies such as metabolic tracing.

HY-Y0479S

L-Lactic acid-13C3

L-Lactic acid- ¹³C₃ is a stable isotope labeled L-Lactic acid analog. L-Lactic acid- ¹³C₃ can be used for lactate metabolism research[1].
HY-111095S3A

D-(-)-Lactic acid-13C-2 sodium

D-(-)-Lactic acid-13C-2 (sodium) is a sodium. D-(-)-Lactic acid-13C-2 (sodium) can be used for a variety of biochemical studies.
HY-Y0479AS

L-Lactic acid-13C3 sodium

L-Lactic acid- ¹³C₃ (sodium) is the ¹³C labeled L-Lactic acid. L-Lactic acid- ¹³C₃ sodium can be used for lactate metabolism research[1].
HY-113099S

Indolelactic acid-d5

Indolelactic acid-d₅ is the deuterium labeled Indolelactic acid. Indolelactic acid is a tryptophan (Trp) catabolite in Azotobacter vinelandii cultures.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

lactic

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

NaturalProducts

Isotope-Labeled Compounds

Natural
Products